Winz Casagrande, Dr. jur., lic.oec.HSG, ICD.D is Founder, CEO and Chair of Delphi Diagnostics Inc.(R), a breast cancer diagnostic company. She has successfully led the organization’s commercialization from inception through several capital raises. Winz is an experienced entrepreneur, executive, and Board Director with a passion for building and growing innovative, sustainable enterprises.
Stefan Engelke is the CEO of Mutschler Holding AG, a Swiss-based single Family Office and holds a number of executive management and board positions in related entities and in portfolio companies. Between 2004 and 2018, Stefan worked for UBS Switzerland in different Wealth Management leadership positions in products & services and in client advisory. From 2001 to 2004, Stefan represented Allianz SE as investor relations officer.
Lisa Matar is a Global Life Science executive with more than 25 years of experience leading organizations and driving significant growth, profitability, and launching excellence across the globe. Lisa served as President and General Manager of Eli Lilly Canada from 2013 to February 2020, and was a member of the North American executive committee at Eli Lilly.
Hansjuergen Overstolz was President of the Bosch Group in Russia, Belarus, Ukraine, the Caucasus, Central Asia, Mongolia and CEO of both, Robert Bosch OOO in Russia and Robert Bosch Ltd. in Georgia until 2021. During his 25-year career with Bosch, he served as Director, Plant GM, Executive Vice President and Chief Financial Officer in Europe, USA and Asia.
Gisela Paulsen is a global life sciences senior executive with operational and P&L experience who combines a science background with strategy, commercialization, and clinical development experience to build, transform, and grow resilient businesses from startups to large companies. Gisela was named the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE in 2019.
Fidel Reijerse is founder and President of RESCo Energy Inc., a solar engineering and construction firm specializing in commercial solar rooftop projects and building energy management. RESCo was founded in 2006 and took on a 50% investment by Flynn Group of Companies in 2010. Previous to RESCo, Fidel was a founder of a data mining firm commercializing IBM algorithms for application in the areas of cancer research combining genetic, environmental and intervention data.